Establishment of an induced pluripotent stem cell line (ZJULLi004-A) from a hypertrophic cardiomyopathy patient carrying MYBPC3/c.3764C>A mutation

Summary

Hypertrophic cardiomyopathy (HCM) is an inherited cardiovascular disease characterized by left ventricular hypertrophy and a high risk of sudden death. In this study, a skin biopsy was obtained from a HCM patient harboring a heterozygous missense mutation (c.3764C>A; p.A1225D) in the myosin binding protein C3 (MYBPC3) gene. The isolated fibroblasts were reprogrammed using non-integrated Sendai viral method to establish the patient-specific induced pluripotent stem cell (iPSC) line. The established iPSC line displayed normal morphology and karyotype, expressed pluripotency markers, and can differentiate into three germ layers in vivo. Copyright © 2022. Published by Elsevier B.V.

Authors Sun Y, Zhou J, Wang H, Wang H, Chen X, Gong T, Liang P, Jiang C
Journal Stem cell research
Publication Date 2022 Aug 23;64:102898
PubMed 36041398
DOI 10.1016/j.scr.2022.102898

Research Projects

Cell Lines